Large-scale manufacture and use of recombinant VP2 vaccine against infectious bursal disease in chickens

Vaccine

Volumn 25, Issue 46, 2007, Pages 7900-7908

  Rong, Jun ^a   Jiang, Taozhen ^b   Cheng, Taipin ^a   Shen, Minghong ^c   Du, Yuanzhao ^d   Li, Shiliang ^d   Wang, Shuming ^d   Xu, Baojuan ^d   Fan, Gencheng ^d  

^a YANGTZE UNIVERSITY   (China)

^b CHINA INSTITUTE OF VETERINARY DRUG CONTROL   (China)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d EBIO Bioengineering Co Ltd of Qingdao   (China)

Author keywords

ELISA; IBDV; Subunit vaccine

Indexed keywords

INFECTIOUS BURSAL DISEASE VIRUS VACCINE; RECOMBINANT PROTEIN; RECOMBINANT PROTEIN VP2; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; BURSA FABRICII; CHICKEN; CONTROLLED STUDY; CORRELATION COEFFICIENT; ENZYME LINKED IMMUNOSORBENT ASSAY; IN VITRO STUDY; INFECTIOUS BURSAL DISEASE; INFECTIOUS BURSAL DISEASE VIRUS; NONHUMAN; ORNITHOSIS; POULTRY; PRIORITY JOURNAL; SEROLOGY; VACCINATION;

ANIMALS; ANTIBODIES, VIRAL; BIRNAVIRIDAE INFECTIONS; CHICKENS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; INFECTIOUS BURSAL DISEASE VIRUS; POULTRY DISEASES; RECOMBINANT PROTEINS; VACCINES, SYNTHETIC; VIRAL STRUCTURAL PROTEINS; VIRAL VACCINES;

EID: 35448958137     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.09.006     Document Type: Article

References (25)

1. Cosgrove A.S. An apparently new disease of chickens-Avian nephrosis. Avian Dis 6 (1962) 385-389
2. Allan W.H., Faragher J.T., and Cullen G.A. Immunosuppression by infectious bursal agent in chickens immunized against Newcastle disease. Vet Rec 90 (1972) 511-512
3. Faragher J.T., Allan W.H., and Wyeth C.J. Immunosuppressive effect of infectious bursal agent in vaccination against Newcastle disease. Vet Rec 95 (1974) 385-388
4. Ivanyi J. Immunodeficency in the chicken. IV. An immunological study of infectious bursal disease. Clin Exp Med 23 (1976) 154-165
5. Wyeth P.J., and Cullen G.A. Maternally derived antibody-effect on susceptibility of chicks to infectious bursal disease. Avian Pathol 5 (1976) 253-260
6. Wyeth P.J., and Cullen G.A. The use of an inactivated infectious bursal disease oil emulsion vaccine in commercial broiler parent chickens. Vet Rec 104 (1979) 188-193
7. Chettle N., Stuart J.C., and Wyeth P.J. Outbreak of virulent infectious bursal disease in East Anglia. Vet Rec 125 (1989) 271-272
8. Chettle N.J., and Wyeth P.J. Failure of maternally derived infectious bursal disease antibodies to serotypes 1 and 2 to protect against heterologous virus. Br Vet J 145 (1989) 165-169
9. Brown M.D., Green P., and Skinner M.A. VP2 sequences of recent European "Very virulent" isolates of infectious bursal disease virus are closely related to each other but are distinct from those of 'classical strains'. J Gen Virol 75 (1994) 675-680
10. Van Den Berg T.P., and Meulemans G. Acute infectious bursal disease in poultry: protection afforded by maternally derived antibodies and interference with live vaccination. Avian Pathol 20 (1991) 409-421
11. Giambrone J.J., Eidson C.S., Page R.K., Fletcher O.J., Barger B.O., and Kleven S.H. Effect of infectious bursal agent on the response of chickens to Newcastle disease and Marek's disease vaccination. Avian Dis 20 (1976) 534-544
12. Pitcovski J., Gutter B., Gallili G., Goldway M., Perelman B., Gross G., et al. Development and large-scale use of recombinant VP2 vaccine for the prevention of infectious bursal disease of chickens. Vaccine 21 (2003) 4736-4743
13. Bayliss C.D., Peters R.W., Cook J.K., Reece R.L., Howes K., Binns M.M., et al. A recombinant fowlpox virus that expresses the VP2 antigen of infectious bursal disease virus induces protection against mortality caused by the virus. Arch Virol 120 (1991) 193-205
14. Darteil R., Bublot M., Laplace E., Bouquet J.F., Audonnet J.C., and Riviere M. Herpesvirus of turkey recombinant viruses expressing infectious bursal disease virus (IBDV) VP2 immunogen induce protection against an IBDV virulent challenge in chickens. Virology 211 (1995) 481-490
15. Sheppard M., Werner W., Tsatas E., McCoy R., Prowse S., and Johnson M. Fowl adenovirus recombinant expressing VP2 of infectious Bursal disease virus induces protective immunity against bursal disease. Arch Virol 143 (1998) 915-930
16. Tsukamoto K., Kojima C., Komori Y., Tanimura N., Mase M., and Yamaguchi S. Protection of chickens against very virulent infectious bursal disease virus (IBDV) and Marek's disease virus (MDV) with a recombinant MDV expressing IBDV VP2. Virology 257 (1999) 352-362
17. Shaw I., and Davison T.F. Protection from IBDV-induced bursal damage by a recombinant fowlpox vaccine, fpIBD1, is dependent on the titre of challenge virus and chicken genotype. Vaccine 18 (2000) 3230-3241
18. Tsukamoto K., Sato T., Saito S., Tanimura N., Hamazaki N., Mase M., et al. Dual-viral vector approach induced strong and long-lasting protective immunity against very virulent infectious bursal disease virus. Virology 269 (2000) 257-267
19. Francois A., Eterrandossi N., Delmas B., Payet V., and Langlois P. Construction of avian adenovirus CELO recombinants in cosmids. J Virol 75 (2001) 5288-5301
20. Phenix K.V., Wark K., Luke C.J., Skinner M.A., Smyth J.A., Mawhinney K.A., et al. Recombinant Semliki forest virus vector exhibits potential for avian virus vaccine development. Vaccine 19 (2001) 3116-3123
21. Azad A.A., McKern N.M., Macreadie I.G., Failla P., Heine H.G., Chapman A., et al. Physicochemical and immunological characterization of recombinant host-protective antigen (VP2) of infectious bursal disease virus. Vaccine 10 (1991) 15-22
22. Rong J., Cheng T.P., Liu X.N., Jiang T.Z., Gu H., and Zou G.L. Development of recombinant VP2 vaccine for the prevention of infectious bursal disease of chickens. Vaccine 23 (2005) 4844-4851
23. L promoter. Chin J Virol 6 (1990) 112-116
24. Eterradossi N., Picault J.P., Drouin P., Guittet M., L'Hospitalier R., and Bennejean G. Pathogenicity and preliminary antigenic characterization of six infectious bursal disease virus strains isolated in France from acute outbreaks. Zentralbl Veterinarmed B39 (1992) 683-691
25. Martinez-Torrecuadrada J.L., Lazaro B., Rodriguez J.F., and Casal J.I. Antigenic properties and diagnostic potential of bacuovirus-expressed infectious bural disease virus proteins VPX and VP3. Clin Diagn Lab Immunol 7 (2000) 645-651